{"DataElement":{"publicId":"10939366","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy Delay Reason","preferredDefinition":"Response indicating the reason for conditioning chemotherapy delay.","longName":"DLYREAS_CCHEMO_FAORRES","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"10938240","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy Delay","preferredDefinition":"The destruction of lymphocytes and T cells prior to immunotherapy._Chemotherapy used before transplantation to destroy a patient's cancer cells and provide immunosuppression.:Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","longName":"10938239v1.00:2718948v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"10938239","version":"1","preferredName":"Lymphodepletion Therapy Conditioning Chemotherapy","preferredDefinition":"The destruction of lymphocytes and T cells prior to immunotherapy._Chemotherapy used before transplantation to destroy a patient's cancer cells and provide immunosuppression.","longName":"C165275:C188745","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphodepletion Therapy","conceptCode":"C165275","definition":"The destruction of lymphocytes prior to immunotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Conditioning Chemotherapy","conceptCode":"C188745","definition":"Chemotherapy used before transplantation to destroy a patient's cancer cells and provide immunosuppression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56B8A91-3E8A-1BEC-E053-731AD00A9628","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2718948","version":"1","preferredName":"Delay","preferredDefinition":"Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.","longName":"C25476","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433B5669-BDBA-05BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-08","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2008-01-08","modifiedBy":"ONEDATA","dateModified":"2008-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56B8A91-3E8B-1BEC-E053-731AD00A9628","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10939340","version":"1","preferredName":"Therapy Delay Reason","preferredDefinition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._An explanation of the cause of some phenomenon or action.","longName":"10939340v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Evidence or suspicion of infection","valueDescription":null,"ValueMeaning":{"publicId":"10939356","version":"1","preferredName":"Infection Suspected","longName":"10939356v1.00","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._Believed likely.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Suspected","conceptCode":"C71458","definition":"Believed likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D4CF2-0040-55B2-E053-731AD00AA796","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D4CF2-0043-55B2-E053-731AD00AA796","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","deletedIndicator":"No"},{"value":"Changes in bone marrow, renal, hepatic, pulmonary, or cardiac function since date of informed consent","valueDescription":null,"ValueMeaning":{"publicId":"10939357","version":"1","preferredName":"Changes in bone marrow, renal, hepatic, pulmonary, or cardiac function since date of informed consent","longName":"10939357v1.00","preferredDefinition":"Changes in bone marrow, renal, hepatic, pulmonary, or cardiac function since date of informed consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D4CF2-0041-55B2-E053-731AD00AA796","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D4CF2-0044-55B2-E053-731AD00AA796","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","deletedIndicator":"No"},{"value":"Acute neurological toxicity > grade 1 (with exception of peripheral neuropathy)","valueDescription":null,"ValueMeaning":{"publicId":"10939358","version":"1","preferredName":"Acute Neurotoxicity Syndrome","longName":"10939358v1.00","preferredDefinition":"Having a severe and rapid onset of symptoms with short duration._A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute","conceptCode":"C14140","definition":"Having a severe and rapid onset of symptoms with short duration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neurotoxicity Syndrome","conceptCode":"C27961","definition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D4CF2-0042-55B2-E053-731AD00AA796","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D4CF2-0045-55B2-E053-731AD00AA796","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","deletedIndicator":"No"},{"value":"Repeated screening assessment results are outside eligibility criteria","valueDescription":null,"ValueMeaning":{"publicId":"6944901","version":"1","preferredName":"Did Not Meet Eligibility Criteria","longName":"6944901","preferredDefinition":"An indication that the subject has not fulfilled the criteria needed to continue to the next study period.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Did Not Meet Eligibility Criteria","conceptCode":"C164344","definition":"An indication that the subject has not fulfilled the criteria needed to continue to the next study period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9374F383-2E85-4E2D-E053-F662850A89EE","latestVersionIndicator":"Yes","beginDate":"2019-09-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-26","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D4CF2-0046-55B2-E053-731AD00AA796","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D4CF2-0047-55B2-E053-731AD00AA796","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","deletedIndicator":"No"},{"value":"CRP is ≥ 100 mg/L","valueDescription":null,"ValueMeaning":{"publicId":"10939361","version":"1","preferredName":"CRP is greater than or equal to 100 mg/L","longName":"10939361v1.00","preferredDefinition":"CRP is greater than or equal to 100 mg/L","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D561B-93D8-5679-E053-731AD00AEE27","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D561B-93DA-5679-E053-731AD00AEE27","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-19","deletedIndicator":"No"},{"value":"Temperature is ≥ 38.0°C within 48 hours prior to conditioning chemotherapy","valueDescription":null,"ValueMeaning":{"publicId":"10939362","version":"1","preferredName":"Temperature is greater than or equal to 38.0°C within 48 hours prior to conditioning chemotherapy","longName":"10939362v1.00","preferredDefinition":"Temperature is greater than or equal to 38.0°C within 48 hours prior to conditioning chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D561B-93D9-5679-E053-731AD00AEE27","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E56D561B-93DB-5679-E053-731AD00AEE27","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-18","deletedIndicator":"No"},{"value":"Serum creatinine < 2 x ULN, estimated GFR > 30 mL/min/1.73m2","valueDescription":null,"ValueMeaning":{"publicId":"11129576","version":"1","preferredName":"Serum creatinine < 2 x ULN, estimated GFR > 30 mL/min/1.73m2","longName":"11129576v1.00","preferredDefinition":"Serum creatinine < 2 x ULN, estimated GFR > 30 mL/min/1.73m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6662BE2-E76C-642B-E053-731AD00AAD48","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-16","modifiedBy":"TSESU","dateModified":"2022-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6662BE2-E76D-642B-E053-731AD00AAD48","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-16","modifiedBy":"TSESU","dateModified":"2022-08-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"11129577","version":"1","preferredName":"Delay Reason","preferredDefinition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._An explanation of the cause of some phenomenon or action.","longName":"11129577v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E66869A7-7FE4-328C-E053-731AD00ADC1C","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-16","modifiedBy":"TSESU","dateModified":"2022-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56BF9FF-1FF2-2864-E053-731AD00A4EA0","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TX_DELY_RSN","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the reason for the conditioning chemotherapy delay?","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E56D6A1A-3696-58FF-E053-731AD00AF1CC","latestVersionIndicator":"Yes","beginDate":"2022-08-04","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-04","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}